Search Results - "Cochrane, Tara"

Impact and utility of follicular lymphoma GELF criteria in routine care: an Australasian Lymphoma Alliance study by Barraclough, Allison, Agrawal, Shivam, Talaulikar, Dipti, Chong, Geoffrey, Yoo, Edward, Cheah, Chan Y, Franco, Nunzio, Nguyen, Bianca, Mutsando, Howard, Tahir, Fatima, Trotman, Judith, Huang, Jing, Keane, Colm, Lincoln, Mitchel, Cochrane, Tara, Johnston, Anna M, Dickinson, Michael, Opat, Stephen, McQuilten, Zoe K, Wood, Erica M, St George, Gayathri, Hawkes, Eliza A

“…Follicular lymphoma (FL) treatment initiation is largely determined by tumor burden and symptoms. In the pre-rituximab era, the Group d'Etude des Lymphomes…”
Get full text

A Phase 2 Study of the LSD1 Inhibitor Img-7289 (bomedemstat) for the Treatment of Essential Thrombocythemia (ET) by Palandri, Francesca, Vianelli, Nicola, Ross, David M, Cochrane, Tara, Lane, Steven W, Larsen, Stephen R, Gerds, Aaron T., Halpern, Anna B., Shortt, Jake, Rossetti, James M., Pettit, Kristen M., Jones, Amber, Peppe, Jennifer, Natsoulis, Georges, Navarro, Willis, Hong, Wan-Jen, Stevenson, William S., Harrison, Claire N., Talpaz, Moshe, Rienhoff, Hugh Young

“…▪ Many patients with ET are resistant to or intolerant of current standards of care (SOC) - hydroxyurea (HU), interferon, anagrelide - underscoring the need…”
Get full text

Poor outcomes for trial‐ineligible patients receiving polatuzumab for relapsed/refractory diffuse large B‐cell lymphoma in routine care: An Australian Lymphoma and Related Diseases Registry project by Shaw, Briony, Chung, Eliza, Wellard, Cameron, Yoo, Edward, Bennett, Rory, Birks, Callum, Johnston, Anna, Cheah, Chan Y, Hamad, Nada, Simpson, Jock, Barraclough, Allison, Ku, Matthew, Viiala, Nicholas, Ratnasingam, Sumita, Armytage, Tasman, Cochrane, Tara, Chong, Geoffrey, Lee, Denise, Manos, Kate, Keane, Colm, Wallwork, Stephanie, Opat, Stephen, Hawkes, Eliza A.

“…Polatuzumab vedotin (Pola) is an approved therapy in combination with rituximab and bendamustine for relapsed or refractory diffuse large B‐cell lymphoma…”
Get full text

P1127: FINAL ANALYSIS OF AUSTRALASIAN LEUKAEMIA & LYMPHOMA GROUP NHL29: A PHASE II STUDY OF IBRUTINIB, RITUXIMAB AND MINI‐CHOP IN VERY ELDERLY PATIENTS WITH NEWLY DIAGNOSED DLBCL by Verner, Emma, Johnston, Amanda, Pati, Nalini, Hawkes, Eliza, Peng Lee, Hui, Cochrane, Tara, Yoon Cheah, Chan, Filshie, Robin, Purtill, Duncan, Sia, Hanlon, Enjeti, Anoop K, Brown, Christina, Murphy, Nicholas, Curnow, Jennifer, Lee, Kenneth, Gandhi, Maher, Butcher, Belinda, Trotman, Judith

Get full text

Lenalidomide Consolidation Added to Rituximab Maintenance Therapy in Patients Remaining PET Positive After Treatment for Relapsed Follicular Lymphoma: A Phase 2 Australasian Leukaemia & Lymphoma Group NHL26 Study by Trotman, Judith, Presgrave, Peter, Carradice, Duncan P., Lenton, Douglas Stuart, Gandhi, Maher K., Cochrane, Tara, Badoux, Xavier, Carlson, Julia, Nkhoma, Gloria, Butcher, Belinda, Nikpour, Armin, Fulham, Michael, Johnston, Anna M.

Get full text

Sequential high‐dose methotrexate and cytarabine administration improves outcomes in real‐world patients with primary central nervous system lymphoma: A report from the Australasian Lymphoma Alliance by Tatarczuch, Maciej, Lewis, Katharine Louise, Gunjur, Ashray, Shaw, Briony, Poon, Li Mei, Paul, Erin, Ku, Matthew, Wong, Mark, Ai, Sylvia, Beekman, Ashley, Ciaccio, Pietro R. Di, Krigstein, Michael, Wight, Joel, Coombes, Caitlin, Gilbertson, Michael, Tey, Amanda, Shortt, Jake, Nagarajan, Chandramouli, Talaulikar, Dipti, Hamad, Nada, Ratnasingam, Sumita, Ho, Shir‐Jing, Cochrane, Tara, Hawkes, Eliza A., Cheah, Chan Y., Opat, Stephen, Gregory, Gareth P.

“…Background Despite recent advances, optimal therapeutic approaches applicable to subpopulations with primary central nervous system (CNS) lymphoma outside of…”
Get full text

P1193: POLATUZUMAB, BENDAMUSTINE & RITUXIMAB (POLA‐BR) EFFICACY IN RELAPSED/REFRACTORY DIFFUSE LARGE B CELL LYMPHOMA (RRDLBCL) TRIAL‐INELIGIBLE PATIENTS: AN AUSTRALIAN LYMPHOMA REGISTRY (LARDR) STUDY by Shaw, Briony, Chung, Eliza, Wellard, Cameron, Yoo, Edward, Bennett, Rory, Birks, Callum, Johnston, Anna, Cheah, Chan, Hamad, Nada, Simpson, Jock, Barraclough, Allison, Ku, Matthew, Viiala, Nicholas, Ratnasingam, Sumita, Armytage, Tasman, Cochrane, Tara, Chong, Geoff, Lee, Denise, Manos, Kate, Keane, Colm, Wallwork, Stephanie, Opat, Stephen, Hawkes, Eliza A

Get full text

Acute Stridor and Respiratory Failure due to Retrosternal Subglottic Stenosis of Unknown Origin by Smith, Linda, Cochrane, Tara, Willis, Nicola Jane, Keijzers, Gerben, Vithanage, Tharindu

“…Respiratory failure due to subglottic stenosis is a rare but serious condition. A 22-year-old male presented to the emergency department (ED) with shortness of…”
Get full text

Comparison of a therapeutic platelet transfusion strategy to a prophylactic platelet transfusion strategy in autologous stem cell transplant (ASCT), a single centre experience by Savoia, Camille, McKeough, Nicholas, Hickey, Beth, Cochrane, Tara

Get full text

The flow cytometric characteristics of breast implant‐associated anaplastic large cell lymphoma by Barr, Jordan, Campbell, Heather, McGuire, Lloyd, Cochrane, Tara

Get full text

The importance of the peripheral blood film in indicating a diagnosis of multiple myeloma with cryoglobulinaemia by Hunt, Stewart, Taylor, Jacqueline, Cochrane, Tara

Get full text

First Report of Candidatus Mycoplasma haemohominis Infection in Australia Causing Persistent Fever in an Animal Carer by Alcorn, Kylie, Gerrard, John, Cochrane, Tara, Graham, Rikki, Jennison, Amy, Irwin, Peter J, Barbosa, Amanda D

“…Abstract Background Hemotropic mycoplasmas (hemoplasmas) infect animals and humans and can lead to clinical syndromes mainly characterized by hemolytic anemia…”
Get full text

Alk-positive large B-cell lymphoma: a case report by Foong, Samuel, Nigam, Sonu, Cochrane, Tara

Get full text

Daratumumab plus lenalidomide and dexamethasone versus lenalidomide and dexamethasone in relapsed or refractory multiple myeloma: updated analysis of POLLUX by Dimopoulos, Meletios A, San-Miguel, Jesus, Belch, Andrew, White, Darrell, Benboubker, Lotfi, Cook, Gordon, Leiba, Merav, Morton, James, Ho, P Joy, Kim, Kihyun, Takezako, Naoki, Moreau, Philippe, Kaufman, Jonathan L, Sutherland, Heather J, Lalancette, Marc, Magen, Hila, Iida, Shinsuke, Kim, Jin Seok, Prince, H Miles, Cochrane, Tara, Oriol, Albert, Bahlis, Nizar J, Chari, Ajai, O' Rourke, Lisa, Wu, Kaida, Schecter, Jordan M, Casneuf, Tineke, Chiu, Christopher, Soong, David, Sasser, A Kate, Khokhar, Nushmia Z, Avet-Loiseau, Hervé, Usmani, Saad Z

“…In the POLLUX study, daratumumab plus lenalidomide/dexamethasone significantly reduced risk of progression/death versus lenalidomide/dexamethasone alone in…”
Get full text

Australasian Leukaemia & Lymphoma Group NHL35-Pacific: An Open Label Phase II Study of Pembrolizumab and Chemo-Immunotherapy As First-Line Therapy for Primary Mediastinal B-Cell Lymphoma - Trial in Progress by Lewis, Katharine L., Blombery, Piers, Sungala, Nagendra Prasad, Ma, Chun Kei Kris, Giri, Pratyush, Vanguru, Vinay, Cochrane, Tara, Czerwinski, Joanna Katarzyna, Lee, Denise, Hamad, Nada, Francis, Roslyn, Walia, Mannu, Carlson, Julia, Butcher, Belinda E, Cheah, Chan Y.

“…Background: Primary Mediastinal B-cell Lymphoma (PMBL) comprises 10% of Diffuse large B-cell lymphoma (DLBCL), primarily affecting young adults. Combination…”
Get full text

Lenalidomide Consolidation Added to Rituximab Maintenance Therapy in Patients Remaining PET Positive after Treatment for Relapsed Follicular Lymphoma: Phase 2 Australasian Leukaemia & Lymphoma Group NHL26 Study by Trotman, Judith, Presgrave, Peter, Carradice, Duncan P., Lenton, Douglas Stuart, Gandhi, Maher, Cochrane, Tara, Badoux, Xavier, Nkhoma, Gloria, Butcher, Belinda, Fulham, Michael, Johnston, Anna

“…Introduction The combination of rituximab & lenalidomide (R 2) is an established regimen for treatment of follicular lymphoma (FL), with efficacy reported in…”
Get full text

Updated quality of life data from the phase 3b VENICE II trial: patients with relapsed or refractory chronic lymphocytic leukemia receiving venetoclax monotherapy by Cochrane, Tara, Enrico, Alicia, Gomez-Almaguer, David, Hadjiev, Evgueniy, Lech-Maranda, Ewa, Masszi, Tamas, Nikitin, Eugene, Robak, Tadeusz, Weinkove, Robert, Wu, Shang-Ju, Manzoor, Beenish S., Busman, Todd, Pai, Madhavi, Komlosi, Viktor, Anderson, Mary Ann

Get full text

Characteristics and Outcomes of Elderly Patients with Classical Hodgkin Lymphoma (cHL): An Australian Lymphoma Alliance (ALA), and Lymphoma and Related Disease Registry (LaRDR) Study by Goh, Zhong, Latimer, Maya, Lewis, Katharine L., Cheah, Chan Yoon, Di Ciaccio, Pietro, Cushion, Tania, Hawkes, Eliza, Harrop, Sean, Ku, Matthew, Campbell, Ashlea, Hamad, Nada, Wood, Erica M., Chung, Eliza, Chen, Pin-Yen, Cochrane, Tara

Get full text

A Phase 1/2, First-in-Human, Multicenter, Open-Label, Dose Escalation and Dose-Expansion Study of Single-Agent ISB 1442 in Patients with Relapsed/Refractory Multiple Myeloma by Sia, Hanlon, Tan, Peter T., Richter, Joshua, Ho, Phoebe Joy, Cochrane, Tara, Quach, Hang, Dhakal, Binod, Proscurshim, Igor, Jiang, Tony, Mancino, Emaryn, Salhi, Yacine, Stefano, Sammicheli, Gudi, Girish, Garton, Andrew, Feldman, Eric J., Spencer, Andrew

Get full text

Infection risk and antimicrobial prophylaxis in bendamustine-treated patients with indolent non-Hodgkin lymphoma: An Australasian Lymphoma Alliance study by Manos, Kate, Churilov, Leonid, Grigg, Andrew, Di Ciaccio, Pietro, Wong, Jonathan, Chandra Sekaran, Usha, Wight, Joel, Goh, Zhong, Jina, Hayden, Butler, Llewyn, Yannakou, Costas K, Hamad, Nada, Gregory, Gareth P, Gangatharan, Shane, Cochrane, Tara, Hawkes, Eliza A, Lasica, Masa

“…Infection and lymphopenia are established bendamustine-related complications. The relationship between lymphopenia severity and infection risk, and the role of…”
Get full text